Hospital Products in UK Law

Leading Cases
  • Raymond Bieber & Others (Appellants/Claimants) v Teathers Ltd ((in Liquidation)) (Respondent/Defendant)
    • Court of Appeal (Civil Division)
    • 14 November 2012

    It is therefore necessary to be satisfied not merely that the money when paid was not at the free disposal of the payee but that, objectively examined, the contractual or other arrangements properly construed were intended to provide for the preservation of the payor's rights and the control of the use of the money through the medium of a trust.

  • Ross River Ltd and Another in Appeals 28856 v Cambridge City Football Club in Appeal 2849
    • Chancery Division
    • 19 September 2007

    Each case will turn on its own facts, but if the relationship is regulated by a contract, then the terms of that contract will be of primary importance, and wider duties will not lightly be implied, in particular in commercial contracts negotiated at arms' length between parties with comparable bargaining power, and all the more so where the contract in question sets out in detail the extent, for example, of a party's disclosure obligations : see more generally Hospital Products Ltd v United States Surgical Corporation (1984) 156 CLR 41, at 97, where Mason J said this:

  • Attorney General v Blake
    • Court of Appeal (Civil Division)
    • 16 December 1997

    The employee must act in good faith; he must not make a profit out of his trust; he must not place himself in a position where his duty and his interest may conflict; he may not act for his own benefit or the benefit of a third party without the informed consent of his employer.

    In Hospital Products Ltd. v US Surgical Corporation Ltd. (1984) 58 ALJR 587 at p. 620 Deane J indicated that he regarded the question as deserving of reconsideration; and in Jaggard v Sawyer [1995] 1 WLR 269 at p. 281 Sir Thomas Bingham MR expressed the view that the judgments in Surrey County Council v Bredero Homes (1993) 1 WLR 1361 (in which the Court refused to countenance the possibility of awarding restitutionary damages for breach of contract) might "not be the last word on the subject."

  • Medsted Associates Ltd v Canaccord Genuity Wealth (International) Ltd
    • Court of Appeal (Civil Division)
    • 06 February 2019

    As Bowstead and Reynolds say, if the principal knows this, he cannot object on the ground that he did not know the precise particulars of the amount paid. He can, of course, always ask and if he does not like the answer, he can take his business elsewhere. Bowstead does add that where no trade usage is involved (and no usage was alleged in the present case), the principal's knowledge may require to be “more specific”.

    But this statement of principle does not absolve the court from deciding the scope of the fiduciary's obligations. If, in fact, the agent has, in the light of the facts of the case, no obligation to disclose the actual amount of commission he is paid when his principal knows he is being paid by the third party to the transaction, it does not advance the matter to say that, because he is a fiduciary, he must disclose the actual amount he is being paid.

  • Conway v Ratiu and Others
    • Court of Appeal (Civil Division)
    • 08 November 2005

    Where there is a contractual retainer and where it provides expressly or by implication obligations of a fiduciary nature, such obligations must clearly prevail, or "mould" or "inform" the fiduciary nature of the contractual relationship.

See all results
Legislation
  • The Human Medicines Regulations 2012
    • UK Non-devolved
    • January 01, 2012
    ... ... the purposes of section 2(2) of that Act in relation to medicinal products and to measures in the veterinary and phytosanitary fields for the ... are suffering from a progressive disease in its final stages;“hospital” includes a clinic, nursing home or similar institution;“immediate ... ...
  • Health (Tobacco, Nicotine etc. and Care) (Scotland) Act 2016
    • Scotland
    • January 01, 2016
  • The Medicines for Human Use (Clinical Trials) Regulations 2004
    • UK Non-devolved
    • January 01, 2004
    ... ... (2) of the European Communities Act 1972 in relation to medicinal products, in exercise of the powers conferred by the said section 2(2), and of all ... ; and(c) the chief investigator is professionally based at a hospital, health centre, surgery or other establishment or facility in Scotland,the ... ...
  • Finance Act 2022
    • UK Non-devolved
    • January 01, 2022
    ... ... for members of the emergency services or persons working in a hospital;(e) a hospital or hospice;(f) temporary sheltered accommodation;(g) a ... Tobacco products duty ... 77: Rates of tobacco products duty ... (1) In Schedule 1 to ... ...
See all results
Books & Journal Articles
  • The Legal Landscape for Advanced Therapies: Material and Institutional Implementation of European Union Rules in France and the United Kingdom
    • No. 39-1, March 2012
    • Journal of Law and Society
    In 2007, the European Union adopted a lex specialis, Regulation (EC) No. 1394/2007 on advanced therapy medicinal products (ATMPs), a new legal category of medical product in regenerative medicine. ...
    ... ... 1394/2007 on advanced therapy medicinal products (ATMPs), a new legal category of medical product in regenerative medicine ... It also provides a hospital exemption, which means that medicinal products not regulated by EU law do ... ...
  • JCT600 engages expanding team with benefits package
    • No. 12-6, October 2013
    • Strategic HR Review
    • 308-312
    Purpose: – The aim of this paper is to present a case study about how JCT600 has implemented an employee benefits program that offers its staff a comprehensive range of benefits in an engaging and ...
    ... ... Simple protection products were also offered byPersonal Group, namely Voluntary Group Income on (VGIP) and the Hospital Cash Plan. Bothhave been well received with 274 VGIP registrations and 158 ... ...
  • The Impact of Complementary Agglomeration and Multi‐unit Systems on New Product Introduction
    • No. 21-4, December 2010
    • British Journal of Management
    This study explores the relationship between organizational agglomeration and new product introduction. It proposes that product‐complementary agglomeration increases the likelihood of new product ...
    ... ... Product Introduction Hsuan Lo and Hsien-Jui Chung 1 Department of Hospital and Health Care Administration, Chia Nan University of Pharmacy and ... Introduction The introduction of new products and services is a major strategy for organizations pursuing growth ... ...
  • Half-way House Fiduciary Duties: Medsted Associates Ltd v Canaccord Genuity Wealth (International) Ltd
    • No. , September 2019
    • Edinburgh Law Review
    • 388-395
    ... ... generating fiduciary duties.46 The same idea was articulated in Hospital Products,47 a case cited with approval in Medsted and in numerous other ... ...
See all results
Law Firm Commentaries
See all results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT